Get the Stockscreener App
303.19
0.27%
0.83
After Hours:
303.19
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Waters Corp stock is traded at $303.19, with a volume of 823.81K.
It is up +0.27% in the last 24 hours and down -13.97% over the past month.
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.
See More
Previous Close:
$302.36
Open:
$302.53
24h Volume:
823.81K
Relative Volume:
1.25
Market Cap:
$18.04B
Revenue:
$2.91B
Net Income/Loss:
$622.64M
P/E Ratio:
28.93
EPS:
10.48
Net Cash Flow:
$620.14M
1W Performance:
+5.47%
1M Performance:
-13.97%
6M Performance:
-24.98%
1Y Performance:
-5.71%
1-Day Range:
$299.90
$304.99
1-Week Range:
$294.19
$305.87
52-Week Range:
$279.62
$423.56
Waters Corp Stock (WAT) Company Profile
Name
Waters Corp
Sector
Industry
Phone
(508) 478-2000
Address
34 MAPLE ST, MILFORD, MA
Compare WAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
303.19 | 17.99B | 2.91B | 622.64M | 620.14M | 10.48 |
|
TMO
Thermo Fisher Scientific Inc
|
482.16 | 183.07B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
206.85 | 145.32B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
573.07 | 45.56B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
119.84 | 33.96B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
194.55 | 33.62B | 15.50B | 1.33B | 2.16B | 7.34 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-26-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-08-24 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Aug-01-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Nov-13-23 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| May-18-22 | Initiated | Barclays | Overweight |
| May-17-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-25-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-07-21 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-17-20 | Upgrade | Cleveland Research | Underperform → Buy |
| Dec-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Dec-02-20 | Initiated | Goldman | Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-28-20 | Upgrade | JP Morgan | Underweight → Neutral |
| Jul-16-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jan-08-20 | Downgrade | Needham | Hold → Underperform |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Sell |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-09-19 | Downgrade | Barclays | Equal Weight → Underweight |
| Jul-16-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-12-19 | Downgrade | Cleveland Research | Neutral → Underperform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| Jan-24-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-03-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jan-03-19 | Initiated | Needham | Hold |
| Dec-12-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-18 | Downgrade | Goldman | Neutral → Sell |
| Oct-11-18 | Upgrade | Cleveland Research | Sell → Neutral |
View All
Waters Corp Stock (WAT) Latest News
Will Waters Corporation stock benefit from interest rate changesAccurate Technical Trend Reversal Picks Detected - metal.it
What makes Waters Corporation stock price move sharplyFree Signals Group - metal.it
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CRGX, WAT, CORZ on Behalf of Shareholders - GlobeNewswire Inc.
How high can Waters Corporation stock price go in 2025Momentum Buy Alert - metal.it
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: KLG, CAPN, OLO, and WAT - The Malaysian Reserve
What drives Waters Corporation stock priceFree Stock Movement Tracking - Autocar Professional
Waters Corporation Stock Analysis and ForecastHigh-velocity capital appreciation - jammulinksnews.com
What analysts say about Waters Corporation stockHigh-return market picks - Autocar Professional
Inside the deal: Waters CEO Udit Batra defends $17.5B merger with BD unit - The Business Journals
Mass Spectrometry Company Evaluation Report 2025 | Agilent, Thermo Fisher, and Waters Lead with Robust Portfolios, Strategic Expansions, and Innovation-Driven Growth - Yahoo Finance
Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal - MSN
How Is Waters Corporation's Stock Performance Compared to Other Healthcare Stocks? - MSN
Waters Corp (WAT) Shares Decline 3.39% Amid Analyst Forecast - AInvest
Waters downgraded at Wells Fargo after Becton, Dickinson deal - MSN
Waters to buy Becton unit in a $17.5 billion deal amid tariff pressures - MSN
Under CEO Udit Batra's Leadership, Waters to Merge with BD Unit in $17.5 Billion Deal to Create Life Sciences Powerhouse - INDIA New England News
Waters Corp. stock underperforms Friday when compared to competitors - MarketWatch
Enovis, CONMED, Astrana Health, Privia Health, and Waters Corporation Stocks Trade Down, What You Need To Know - Yahoo Finance
Taxation With Representation: Wachtell, Slaughter And May - Law360
Is Waters Corporation a good long term investmentFree Daily Trading Room Entry - jammulinksnews.com
Waters Corporation’s SWOT analysis: stock poised for growth amid biotech boom - Investing.com
Becton to merge unit with Waters in $17.5 billion deal - MSN
What to Expect From Waters Corporation's Next Quarterly Earnings Report - MSN
Waters Corp Is Taking On Thermo Fisher & Danaher With This $17.5 Billion Becton Dickinson Acquisition! - Smartkarma
Waters Corp. stock underperforms Tuesday when compared to competitors - MSN
symbol__ Stock Quote Price and Forecast - CNN
Becton to merge biosciences and diagnostics arm with Waters in $17.5 billion deal - MSN
Waters to merge with Becton's biosciences and diagnostics arm in $17.5 billion deal - MSN
WATERS CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Waters CorporationWAT - Business Wire
Waters (WAT) Stock Target Price Lowered by Baird Analyst | WAT S - GuruFocus
Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks - MSN
Waters (WAT) Price Target Reduced by Baird Analyst | WAT Stock N - GuruFocus
Waters Shares Dip After $17.5 Billion Merger Announcement with BD Biosciences Unit - MSN
Waters stock downgraded at Wells Fargo on BD deal (WAT:NYSE) - Seeking Alpha
Waters Corporation stock hits 52-week low at 297.03 USD By Investing.com - Investing.com Canada
UBS reiterates Neutral rating on Waters stock, maintains $360 price target - Investing.com Nigeria
Waters Corporation stock hits 52-week low at 297.03 USD - Investing.com
UBS reiterates Neutral rating on Waters stock, maintains $360 price target By Investing.com - Investing.com South Africa
Waters deal adds variables to ‘clean’ story, says Jefferies - Yahoo Finance
Waters stock rating reiterated at Hold by Stifel after BDX asset acquisition - Investing.com Nigeria
BD Partners With Waters to Build High-Volume Diagnostics Leader - Yahoo Finance
Beyond The Numbers: 5 Analysts Discuss Waters Stock - Benzinga
Street View: Waters’ $17.5 billion merger draws both optimism and caution - TradingView
Waters stock price target lowered to $330 from $375 at BofA Securities - Investing.com Nigeria
An $18 bln health deal faces risks outside the lab - Reuters
Waters stock price target lowered to $330 from $375 at BofA Securities By Investing.com - Investing.com South Africa
Waters Corp. & BD to become life science and diagnostics leader - ROI-NJ
Five things: Waters, lab leases, Legacy FC, classic cars and an ocean view - The Business Journals
Waters Corporation: A Path to Diversification via the Becton Diagnostics Merger - AInvest
Waters: Becoming A Diversified Giant Following The Becton Diagnostics Merger - Seeking Alpha
Waters' $17.5B BD Deal: A Bold Bet on Life Sciences Resilience Amid Tariff Storms - AInvest
Waters Corp Stock (WAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.57%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):